Developing a SARS-CoV-2 antigen test using engineered affinity proteins

The ongoing COVID-19 pandemic has clearly established how vital rapid, widely accessible diagnostic tests are in controlling infectious diseases and how difficult and slow it is to scale existing technologies. Here, we demonstrate the use of the rapid affinity pair identification via directed select...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seunghyeon, Yee, Emma, Miller, Eric A., Hao, Yining, Tay, Dousabel M. Y., Sung, Ki-Joo, Jia, Huan, Johnson, Joseph M., Saeed, Mohsan, Mace, Charles R., Yurt, Deniz Yüksel, Sikes, Hadley D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ChemRxiv 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132241/
https://www.ncbi.nlm.nih.gov/pubmed/34013166
http://dx.doi.org/10.26434/chemrxiv.14442785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132241/
https://www.ncbi.nlm.nih.gov/pubmed/34013166
http://dx.doi.org/10.26434/chemrxiv.14442785

Ejemplares similares